Chongqing Pharscin Pharmaceutical Co., Ltd. (SHE:002907)

Market Cap	5.43B -23.2%
Revenue (ttm)	850.29M +8.1%
Net Income	93.83M +25.8%
EPS	0.22 +25.8%
Shares Out	417.60M
PE Ratio	57.85
Forward PE	n/a
Dividend	0.08 (0.58%)
Ex-Dividend Date	Sep 4, 2026

Volume	6,254,500
Open	13.07
Previous Close	13.39
Day's Range	12.92 - 13.45
52-Week Range	11.42 - 18.47
Beta	-0.11
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 27, 2026

About SHE:002907

Chongqing Pharscin Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of drugs in China and internationally. It offers generic drugs, traditional Chinese medicines, and food for special medical purposes in various forms, including tablets, granules, capsules, soft capsules, powders, powder injections, lyophilized powder injections, small-volume injections, chemical raw materials, and traditional Chinese medicine extracts. The company is also involved in the provision of CDMO and ...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1996
• Employees: 1,439
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 002907

Financial Performance

In 2025, SHE:002907's revenue was 827.14 million, an increase of 6.75% compared to the previous year's 774.82 million. Earnings were 65.09 million, a decrease of -15.17%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Nov 13, 2026

Data Sources Report a data error